Obliteride Dollars Matter
Our fundraising helps Fred Hutch researchers advance the groundbreaking science it takes to accelerate discovery and change the world. We don’t know which dollar will fuel the next breakthrough — so every dollar matters.
Since 2013, Obliteride funding has helped advance:
- New approaches for breast, colon, pancreatic, prostate and other cancers.
- Breakthroughs in data science.
- Community partnerships that improve health outcomes.
- Novel therapies that retrain the body’s immune cells to attack cancers.
- Powerful insights into diet, genetics, environmental factors, and cancer risk.
In 2024, Obliteriders supported:
27
Disease areas
84
Faculty and clinicians
26
Programs and specialties
Highlights
Lymphoma
Lymphomas are cancers that strike immune cells within the lymphatic system. Many cases can be cured. Our goal is to cure all cases and help people thrive. Fred Hutch scientists are developing and testing new drugs and advancing tests to guide treatment. Our research also includes long-term studies to understand how survivors fare years after treatment.
Yaw A. Nyame, MD, MS, MBA
Black men and those of African descent are 60% more likely to be diagnosed with prostate cancer — and more than twice as likely to die from it. Dr. Nyame, a urologist and surgeon at Fred Hutch and UW Medicine (and an Obliterider) works with patients, the community, and advocates to understand the causes of this disparity, find solutions, and save lives.
Cancer Prevention and Early Detection
Our experts collaborate in the lab, clinic, and community to strengthen prevention and detection for all communities. We dig into environmental, genetic, and behavioral risk factors. Develop and test novel and less invasive screening and tracking methods. Find realistic ways to help people eat healthier, stop smoking, and access screening. And work to stop disease before it starts.
I’ve seen first-hand the lifesaving therapies that have been developed right here at Fred Hutch, some that were once unimaginable. This progress is fueled by the support of people like you and me.
Sandi Navarro, PhD; Fred Hutch Senior Staff Scientist; Team Captain of 'Team Orange'
About Fred Hutch
Fred Hutch Cancer Center unites individualized care and advanced research to provide the latest cancer treatment options while accelerating discoveries that prevent, treat and cure cancer and infectious diseases worldwide.
Based in Seattle, Fred Hutch is an independent, nonprofit organization and the only National Cancer Institute-designated cancer center in Washington. We have earned a global reputation for our track record of discoveries in cancer, infectious disease and basic research, including important advances in bone marrow transplantation, immunotherapy, HIV/AIDS prevention and COVID-19 vaccines. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services. Fred Hutch also serves as UW Medicine’s cancer program. Learn more about Fred Hutch.
As we mark our 50th anniversary in 2025, Fred Hutch is looking beyond what’s possible today to a new era of discovery. With your partnership, our Campaign for Fred Hutch will transform the pace and scale of innovation so we can redefine cancer and infectious disease for generations to come.
Fred Hutch Cancer Center is an independent, nonprofit organization that also serves as the cancer program for UW Medicine. Our relationship allows for enhanced care coordination between a top-ranked cancer center and a leading integrated health system and accelerates the latest scientific breakthroughs in cancer and other life-threatening diseases.
Fred Hutch is proud to raise funds that fuel the adult oncology program on behalf of both Fred Hutch and UW Medicine.